Experiment 973483
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Ginkgo biloba (GINKGOACEAE) |
| Citation | BURKARD,G: LEHRL,S:. (1991). RATIO OF MULTI-INFARCT DEMENTIA AND ALZHEIMER'S DEMENTIA IN PRACTICES OF ESTABLISHED PHYSICIANS.. 133() |
| Amount utilized | |
| Compound isolated | |
| Disease | THE PRESENT PAPER REPORTS ON THE RESULTS OF A DRUG-MONITORING STUDY WITH A GINKGO BILOBA SPECIAL EXTRACT IN WHICH 1357 DOCTORS AND 13 556 OUTPATIENTS WERE INVOLVED. THE FOLLOWING QUESTIONS WERE INVESTIGATED: IS THE RATIO AMONG DEMENTIAS LIKE THE PRIMARY DEGENERATIVE (ALZHEIMER'S DISEASE/DAT), THE MULTI-INFART DEMENTIA (MID) AND MIXED FORMS THE SAME AS IN CLINICS? DO DOCTORS IN PRACTICE TEND TO PREFER ANY ONE TYPE OF DEMENTIA WHEN PRESCRIBING THERAPY WITH A GINKGO BILOBA PREPARATION? ARE DIFFERENT THERAPEUTIC EFFECTS OR SIDE EFFECTS TO BE EXPECTED DEPENDING ON THE TYPE OF DEMENTIA? ASSUMING THE VALIDITY OF THE USED ISCHAEMIA-SCORE ACCORDING TO HACHINSKI PROVEN ELSE-WHERE, THE RESULT SHOWS THAT THERE ARE MANY MORE MID(42%) AND MIXED TYPES (32%) IN PRACTICE THAN QUOTED IN THE LITERATURE. IN THE DRUG THERAPY WITH GINKGO BILOBA PREPARATION NO TYPE OF DEMENTIA WAS PREFERRED. FOR ALL 3 TYPES A SIGNIFICANT IMPROVEMENT OF THE SYMPTOMS WAS SHOWN, BUT WITHOUT DIFFERENTIAL EFFECT OR DIFFERENT TOLERANCE OF THE MEDICATION. OF 10 815 OUTPATIENTS WHO WERE TESTED WITH THE GINKGO PREPARATION, 183 (1.69%) HAD SIDE EFFECTS OF 5.42% FOR 2141 OUTPATIENTS WHO WERE GIVEN COMPARABLE PREPARATONS, PREDOMINANTLY OF SYNTHETIC NATURE FOR THE SAME INDICATION. |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Extract | ETOH(30%)EXT |